Delivery Order SPE2DB24D3013-SPE2DB25FFNUV
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.72 firm fixed-price delivery order is for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a vaginal estrogen medication. The contract has a period of performance through November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ESTRING 7.5 MCG/DAY (2MG) RINGS. The contract has a potential value of $1,266.66 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
- This federal contract award is for the delivery of ESTRING 2 MG VAGINAL RINGS to the Defense Logistics Agency (DLA). The $1,151.99 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 22, 2022 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $4,732.87 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561345550 ESTRING 2 MG VAGINAL RINGS. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 26, 2023 through June 27, 2023. No set aside designation or subcontracting details were...
- This federal contract award is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,509.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of March 21, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ESTRING 7.5 MCG/DAY (2MG) RINGS. The contract has a potential value of $1,055.55 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not part of a larger contract vehicle. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a...
- The Defense Logistics Agency awarded a $1,320.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562158449 ESTRING 7.5 MCG/DAY (2MG) RINGS. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 13, 2023 through September 14, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ESTRING 7.5 MCG/DAY (2MG) RINGS. The contract has a potential value of $1,055.55 and a completion date of February 12, 2024. The contract supports DLA Troop Support Medical in providing pharmaceuticals and medical supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS. The contract has a ceiling value of $1,459.08 and a completion date of February 14, 2025. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract...
- This delivery order contract, valued at $2,458.12, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Estring 2 mg vaginal rings. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as a...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNUVDelivery Order
The Defense Logistics Agency awarded a $1,741.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2mg) vaginal rings on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-competitive delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems with an extensive portfolio of medications and medical supplies. This delivery order for hormone replacement therapy products exemplifies the company's role as a comprehensive pharmaceutical prime vendor within the DLA's global medical supply chain. The contract's minimal ceiling value reflects a routine replenishment transaction within a larger strategic healthcare procurement framework designed to ensure continuous availability of pharmaceutical commodities to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/29/25 |